Understanding Adenomatous Polyp of Colon (Colonic Adenoma, Colon Adenomatous Polyp) is crucial for accurate healthcare documentation and medical coding. This page provides information on diagnosis, clinical characteristics, and relevant medical coding terms for Adenomatous Polyps of the Colon, supporting healthcare professionals in proper clinical documentation and coding practices. Learn more about the diagnosis, treatment, and management of Adenomatous Polyps of the Colon for improved patient care and accurate medical records.
Benign growth in the colon lining, can become cancerous.
Often asymptomatic, may cause bleeding, changes in bowel habits.
Detected during colonoscopy, sigmoidoscopy, or virtual colonoscopy.
Complete code families applicable to D12.6
| Description | When to use |
|---|---|
| Benign colon growth, can become cancerous. | Use for pre-cancerous polyps found in the colon during colonoscopy. |
| Cancerous colon growth, often arises from adenomas. | Use for malignant neoplasms of the colon confirmed by biopsy. Consider stage and location. |
| Non-neoplastic colon polyp, typically serrated. | Use for serrated polyps, hyperplastic polyps found in colon. Generally, these are benign. |
Lack of size specification (e.g., <1cm vs >1cm) impacts surveillance guidelines and coding accuracy (ICD-10-CM K63.5 vs specific codes).
Insufficient histology description (e.g., tubular, villous) can lead to incorrect coding and affect treatment planning (ICD-10-CM D12.6).
Unclear documentation of polyp count can cause coding errors and affect surveillance frequency (ICD-10-CM D12.7 for multiple polyps).
Confirm polyp location in colon via colonoscopy documentation. ICD-10: K63.5
Verify adenoma histology report. SNOMED CT: 399449004
Assess polyp size, number, and morphology for risk stratification. CPT: 45380
Document dysplasia grade (low/high) in pathology. Patient safety: adenoma surveillance
Patient presents with concerns regarding colon polyps, prompting evaluation for adenomatous polyp of colon (also known as colonic adenoma or colon adenomatous polyp). Symptoms reported include [insert patient-specific symptoms, e.g., rectal bleeding, changes in bowel habits, abdominal discomfort, or asymptomatic screening finding]. Past medical history is significant for [list relevant medical history, e.g., family history of colon cancer, inflammatory bowel disease, previous colonoscopies]. Physical examination revealed [document relevant findings, e.g., normal abdominal examination, or palpable abdominal mass]. A colonoscopy was performed, revealing [describe polyp characteristics, e.g., a [size] cm sessile/pedunculated polyp in the [location] colon]. The polyp was removed via [polypectomy technique, e.g., snare polypectomy, cold forceps polypectomy] and sent for histopathological analysis. Pathology report confirms the diagnosis of adenomatous polyp of the colon, specifying the subtype as [e.g., tubular, tubulovillous, villous] and noting [mention high-risk features if present, e.g., high-grade dysplasia, villous component]. Assessment includes adenomatous polyp of colon, ICD-10 code K63.5. Plan includes surveillance colonoscopy in [ timeframe based on guidelines] and patient education regarding colon cancer screening guidelines, dietary modifications, and lifestyle changes to reduce risk factors for colon cancer. The patient was advised on the importance of follow-up and potential complications, including recurrence and malignant transformation. Further management will be based on the final pathology report and clinical guidelines for colon polyp surveillance.
Surveillance guidelines for adenomatous polyps of the colon post-polypectomy are risk-stratified based on several factors, including size, histology, and number of polyps detected. For patients with one or two small (<1 cm) tubular adenomas with low-grade dysplasia, a repeat colonoscopy is generally recommended in 5-10 years. However, for patients with three to ten adenomas, high-grade dysplasia, villous features, or any adenoma ≥1 cm, surveillance colonoscopy is often advised in 3 years. In cases of more than ten adenomas, a shorter interval, even within one year, or further investigation for potential underlying syndromes, like familial adenomatous polyposis (FAP), may be necessary. These recommendations are based on guidelines from reputable organizations such as the US Multi-Society Task Force on Colorectal Cancer and the American College of Gastroenterology. Consider implementing a risk-stratified approach to post-polypectomy surveillance in your practice to ensure appropriate follow-up for each individual patient. Explore how integrating electronic health record reminders can facilitate timely colonoscopy referrals.
Differentiating between hyperplastic and adenomatous polyps during colonoscopy can be challenging, but certain visual cues can be helpful. Hyperplastic polyps typically appear sessile and smooth, often with a slightly paler color than the surrounding mucosa. Adenomatous polyps, on the other hand, can exhibit a more varied morphology, ranging from sessile to pedunculated and may have a more reddish or velvety appearance. Definitive diagnosis, however, relies on histopathological examination. Hyperplastic polyps demonstrate serrated architecture without significant cytological dysplasia, confined to the upper portion of the crypt. Adenomatous polyps, conversely, show nuclear stratification, hyperchromasia, and architectural abnormalities extending to the base of the crypt, indicative of neoplastic potential. Accurate differentiation is crucial as adenomatous polyps carry a risk of malignant transformation, while hyperplastic polyps, especially small (<1 cm) and located in the distal colon and rectum, are generally considered low risk. Learn more about advanced endoscopic imaging techniques, such as narrow-band imaging (NBI) and chromoendoscopy, that can aid in differentiating polyp types during colonoscopy.
Managing large (>2cm) sessile adenomatous polyps of the colon often requires a nuanced approach. Endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) may be considered. EMR is generally preferred for smaller lesions, while ESD is more appropriate for larger, flat lesions that cannot be reliably removed en bloc with EMR due to a higher risk of incomplete resection and recurrence. Accurate assessment of polyp size, location, and morphology is crucial for choosing the most appropriate technique. For lesions that are not amenable to endoscopic resection, surgical intervention may be necessary. Post-polypectomy surveillance is critical, especially for large sessile adenomas. The interval for follow-up colonoscopy is typically shorter (3-6 months) than for smaller polyps to assess for complete resection and ensure no residual or recurrent adenomatous tissue. Explore how implementing enhanced surveillance strategies can improve long-term outcomes for patients with large sessile adenomatous polyps. Consider incorporating advanced endoscopic imaging techniques into your practice to aid in the accurate characterization of these lesions.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.